{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:22:52Z","timestamp":1792592572586,"version":"4.5.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.lpm.2024.104247","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T14:25:53Z","timestamp":1725632753000},"page":"104247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of thrombophilia on venous thromboembolism management"],"prefix":"10.1016","volume":"53","author":[{"given":"Joseph","family":"Emmerich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Zuily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Gouin-Thibault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Emmanuel","family":"Morange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Couturaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menno","family":"Huisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2024.104247_bib0001","series-title":"Hemostasis and thrombosis. basic principles and clinical practice","article-title":"Thrombophilia genetics","author":"Emmerich","year":"2013"},{"key":"10.1016\/j.lpm.2024.104247_bib0002","first-page":"167","article-title":"Introduction: hypercoagulable states","volume":"34","author":"Bertina","year":"1997","journal-title":"Semin Hematol"},{"key":"10.1016\/j.lpm.2024.104247_bib0003","first-page":"516","article-title":"Inherited antithrombin deficiency causing thrombophilia","volume":"13","author":"Egeberg","year":"1965","journal-title":"Thromb Diath Haemorrh"},{"key":"10.1016\/j.lpm.2024.104247_bib0004","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1172\/JCI111632","article-title":"Familial protein S deficiency is associated with recurrent thrombosis","volume":"74","author":"Comp","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lpm.2024.104247_bib0005","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI110385","article-title":"Deficiency of protein C in congenital thrombotic disease","volume":"68","author":"Griffin","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lpm.2024.104247_bib0006","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1182\/blood.V64.6.1297.1297","article-title":"Plasma protein S deficiency in familial thrombotic disease","volume":"64","author":"Schwarz","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2024.104247_bib0007","first-page":"171","article-title":"Risk factors for venous thrombosis: prevalence, risk, and interaction","volume":"34","author":"Rosendaal","year":"1997","journal-title":"Semin Hematol"},{"key":"10.1016\/j.lpm.2024.104247_bib0008","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(98)10266-0","article-title":"Venous thrombosis: a multicausal disease","volume":"353","author":"Rosendaal","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2024.104247_bib0009","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(10)60709-X","article-title":"Antiphospholipid syndrome","volume":"376","author":"Ruiz-Irastorza","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2024.104247_bib0010","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1055\/s-0037-1616205","article-title":"Genetic approach to thrombophilia","volume":"86","author":"Bertina","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lpm.2024.104247_bib0011","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1161\/01.ATV.19.4.1026","article-title":"Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: a multicenter collaborative family study","volume":"19","author":"Bucciarelli","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.lpm.2024.104247_bib0012","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1182\/blood.V92.7.2353","article-title":"Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families","volume":"92","author":"Martinelli","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2024.104247_bib0013","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1055\/s-0037-1614442","article-title":"Incidence of venous thromboembolism in families with inherited thrombophilia","volume":"81","author":"Simioni","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lpm.2024.104247_bib0014","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1056\/NEJM200104193441607","article-title":"Genetic susceptibility to venous thrombosis","volume":"344","author":"Seligsohn","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2024.104247_bib0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1055\/s-0038-1655930","article-title":"Antithrombin mutation database: 2nd (1997) update. For the plasma coagulation inhibitors subcommittee of the scientific and standardization committee of the international society on thrombosis and haemostasis","volume":"77","author":"Lane","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lpm.2024.104247_bib0016","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1538-7836.2005.01197.x","article-title":"Risk of first venous thrombotic event in carriers of a familial thrombophilic defect. The European prospective cohort on thrombophilia (EPCOT)","volume":"3","author":"Vossen","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.lpm.2024.104247_bib0017","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1055\/s-0037-1616525","article-title":"Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism","volume":"86","author":"Kuhle","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lpm.2024.104247_bib0018","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1182\/blood-2002-11-3391","article-title":"Antithrombin Phe229Leu: a new homozygous variant leading to spontaneous antithrombin polymerization in vivo associated with severe childhood thrombosis","volume":"102","author":"Picard","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2024.104247_bib0019","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/01.ATV.12.2.135","article-title":"The protein C anticoagulant pathway","volume":"12","author":"Esmon","year":"1992","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.lpm.2024.104247_bib0020","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1055\/s-0037-1613883","article-title":"The endothelial cell protein C receptor","volume":"83","author":"Esmon","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lpm.2024.104247_bib0021","doi-asserted-by":"crossref","first-page":"27852","DOI":"10.1074\/jbc.270.46.27852","article-title":"Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C","volume":"270","author":"Rosing","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lpm.2024.104247_bib0022","doi-asserted-by":"crossref","first-page":"18735","DOI":"10.1016\/S0021-9258(17)32228-7","article-title":"Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa","volume":"269","author":"Shen","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lpm.2024.104247_bib0023","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1161\/ATVBAHA.108.177436","article-title":"Protein S as cofactor for TFPI","volume":"12","author":"Hackeng","year":"2009","journal-title":"Arterioscl Thromb vasc Biol"},{"key":"10.1016\/j.lpm.2024.104247_bib0024","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1182\/blood.V79.12.3203.3203","article-title":"Reevaluation of total, free, and bound protein S and C4b-binding protein levels in plasma anticoagulated with citrate or hirudin","volume":"79","author":"Griffin","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2024.104247_bib0025","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0140-6736(93)90003-Y","article-title":"Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect","volume":"341","author":"Allaart","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2024.104247_bib0026","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1182\/blood.V85.10.2756.bloodjournal85102756","article-title":"Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study)","volume":"85","author":"Koster","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2024.104247_bib0027","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1111\/j.1365-2516.2008.01775.x","article-title":"Protein S deficiency: a clinical perspective","volume":"14","author":"Ten Kate","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.lpm.2024.104247_bib0028","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1182\/blood.V85.12.3524.bloodjournal85123524","article-title":"Evaluation of the relationship between protein S and C4b-binding protein isoforms in hereditary protein S deficiency demonstrating type I and type III deficiencies to be phenotypic variants of the same genetic disease","volume":"85","author":"Zoller","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2024.104247_bib0029","first-page":"201","article-title":"Protein S deficiency: a database of mutations. For the plasma coagulation inhibitors subcommittee of the scientific and standardization committee of the international society on thrombosis and haemostasis","volume":"77","author":"Gandrille","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lpm.2024.104247_bib0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1182\/blood.V65.1.15.15","article-title":"Neonatal purpura fulminans: a genetic disorder related to the absence of protein C in blood","volume":"65","author":"Marciniak","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2024.104247_bib0031","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199111283252207","article-title":"Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate","volume":"325","author":"Dreyfus","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2024.104247_bib0032","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1055\/s-0038-1642512","article-title":"Homozygous protein S deficiency due to a one base pair deletion that leads to a stop codon in exon III of the protein S gene","volume":"71","author":"Gomez","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lpm.2024.104247_bib0033","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1073\/pnas.90.3.1004","article-title":"Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C","volume":"90","author":"Dahlback","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.lpm.2024.104247_bib0034","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1538-7836.2003.00016.x","article-title":"The discovery of activated protein C resistance","volume":"1","author":"Dahlback","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.lpm.2024.104247_bib0035","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(05)80081-9","article-title":"Venous thrombosis due to poor anticoagulant response to activated protein C: leiden thrombophilia study","volume":"342","author":"Koster","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2024.104247_bib0036","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJM199402243300801","article-title":"Resistance to activated protein C as a basis for venous thrombosis","volume":"330","author":"Svensson","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2024.104247_bib0037","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to activated protein C","volume":"369","author":"Bertina","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.lpm.2024.104247_bib0038","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1538-7836.2009.03711.x","article-title":"APC resistance: biological basis and acquired influences","volume":"8","author":"Castoldi","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.lpm.2024.104247_bib0039","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0140-6736(94)92940-8","article-title":"Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis","volume":"343","author":"Zoller","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2024.104247_bib0040","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(94)92939-4","article-title":"Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V","volume":"343","author":"Voorberg","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2024.104247_bib0041","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0140-6736(95)91803-5","article-title":"World distribution of factor V Leiden","volume":"346","author":"Rees","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2024.104247_bib0042","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1182\/blood.V89.2.397","article-title":"A single genetic origin for a common Caucasian risk factor for venous thrombosis","volume":"89","author":"Zivelin","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2024.104247_bib0043","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-0037-1614222","article-title":"Factor V Q506 mutation (activated protein C resistance) associated with reduced intrapartum blood loss - a possible evolutionary selection mechanism","volume":"79","author":"Lindqvist","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lpm.2024.104247_bib0044","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1055\/s-0037-1616547","article-title":"Improved hemoglobin status and reduced menstrual blood loss among female carriers of factor V Leiden - an evolutionary advantage?","volume":"86","author":"Lindqvist","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lpm.2024.104247_bib0045","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1055\/s-0037-1616136","article-title":"Study group for pooled-analysis in venous thromboembolism. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism\u2014pooled analysis of 8 case-control studies including 2310 cases and 3204 controls","volume":"86","author":"Emmerich","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lpm.2024.104247_bib0046","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1182\/blood.V99.8.2720","article-title":"A prospective study of venous thromboembolism in relation to factor V Leiden and related factors","volume":"99","author":"Folsom","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2024.104247_bib0047","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/(SICI)1098-2272(1997)14:4<403::AID-GEPI5>3.0.CO;2-3","article-title":"Prevalence of factor V Leiden mutation in various populations","volume":"14","author":"Herrmann","year":"1997","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.lpm.2024.104247_bib0048","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s004390050184","article-title":"The G1691A mutation of the coagulation factor V gene (factor V Leiden) is rare in Chinese: an analysis of 618 individuals","volume":"98","author":"Ko","year":"1996","journal-title":"Hum Genet"},{"key":"10.1016\/j.lpm.2024.104247_bib0049","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000203548","article-title":"Resistance to activated protein C and Arg 506 Gln factor V mutation are uncommon in eastern Asian populations","volume":"98","author":"Kodaira","year":"1997","journal-title":"Acta Haematol"},{"key":"10.1016\/j.lpm.2024.104247_bib0050","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jama.1997.03540400055031","article-title":"Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening","volume":"277","author":"Ridker","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2024.104247_bib0051","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0140-6736(00)02476-4","article-title":"Factor V Leiden paradox: risk of deep-vein thrombosis but not of pulmonary embolism","volume":"356","author":"Bounameaux","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2024.104247_bib0052","doi-asserted-by":"crossref","first-page":"22949","DOI":"10.1074\/jbc.271.38.22949","article-title":"An antifibrinolytic mechanism describing the prothrombotic effect associated with factor V Leiden","volume":"271","author":"Bajzar","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lpm.2024.104247_bib0053","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0002-9343(00)00653-7","article-title":"Factors V Leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis","volume":"110","author":"Meyer","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2024.104247_bib0054","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1182\/blood.V85.6.1504.bloodjournal8561504","article-title":"High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)","volume":"85","author":"Rosendaal","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2024.104247_bib0055","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1055\/s-0038-1656022","article-title":"Clinical features in 36 patients homozygous for the ARG 506 \u2192 GLN factor V mutation","volume":"77","author":"Emmerich","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lpm.2024.104247_bib0056","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1538-7836.2004.00606.x","article-title":"Impact of environmental and hereditary risk factors on the clinical manifestation of thrombophilia in homozygous carriers of factor V:G1691A","volume":"2","author":"Ehrenforth","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.lpm.2024.104247_bib0057","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1161\/01.CIR.92.10.2800","article-title":"Factor V Leiden and risks of recurrent idiopathic venous thromboembolism","volume":"92","author":"Ridker","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2024.104247_bib0058","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJM199702063360602","article-title":"The risk of recurrent venous thromboembolism in patients with an Arg506 \u2192 Gln mutation in the gene for factor V (factor V Leiden)","volume":"336","author":"Simioni","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2024.104247_bib0059","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1182\/blood.V96.10.3329","article-title":"Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis","volume":"96","author":"Simioni","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2024.104247_bib0060","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1055\/s-0038-1656023","article-title":"The risk of recurrent venous thromboembolism in patients with and without factor V Leiden","volume":"77","author":"Eichinger","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lpm.2024.104247_bib0061","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJM199903253401201","article-title":"A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism","volume":"340","author":"Kearon","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2024.104247_bib0062","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM199909093411104","article-title":"The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation","volume":"341","author":"De Stefano","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2024.104247_bib0063","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1055\/s-0037-1614882","article-title":"Coexistence of factor V Leiden and factor II A20210 mutations and recurrent venous thromboembolism","volume":"82","author":"Margaglione","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lpm.2024.104247_bib0064","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJM200008173430702","article-title":"High plasma levels of factor VIII and the risk of recurrent venous thromboembolism","volume":"343","author":"Kyrle","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2024.104247_bib0065","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1001\/archinte.162.20.2357","article-title":"The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism","volume":"162","author":"Eichinger","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.lpm.2024.104247_bib0066","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(03)14111-6","article-title":"Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study","volume":"362","author":"Baglin","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2024.104247_bib0067","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archinte.164.1.92","article-title":"Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism","volume":"16","author":"Eichinger","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.lpm.2024.104247_bib0068","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/CIRCULATIONAHA.109.906347","article-title":"Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A","volume":"121","author":"Lijfering","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2024.104247_bib0069","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood-2002-01-0111","article-title":"Factor V Leiden: the Copenhagen city heart study and 2 meta-analyses","volume":"100","author":"Juul","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2024.104247_bib0070","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","article-title":"A common genetic variation in the 3\u2032-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis","volume":"88","author":"Poort","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2024.104247_bib0071","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1182\/blood.V94.7.2169.419k22_2169_2178","article-title":"Normal\u201d thrombin generation","volume":"94","author":"Butenas","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2024.104247_bib0072","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1161\/01.ATV.18.8.1287","article-title":"Clinical studies and thrombin generation in patients homozygous or heterozygous for the G20210A mutation in the prothrombin gene","volume":"18","author":"Kyrle","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.lpm.2024.104247_bib0073","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1055\/s-0037-1615049","article-title":"Geographic distribution of the 20210 G to A prothrombin variant","volume":"79","author":"Rosendaal","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lpm.2024.104247_bib0074","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1055\/s-0037-1614563","article-title":"Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR","volume":"81","author":"Hessner","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lpm.2024.104247_bib0075","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1182\/blood.V92.4.1119","article-title":"A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene","volume":"92","author":"Zivelin","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.lpm.2024.104247_bib0076","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1055\/s-0037-1615406","article-title":"Homozygous G20210A transition in the prothrombin gene associated with severe venous thrombotic disease: two cases in a French family","volume":"80","author":"Zawadzki","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lpm.2024.104247_bib0077","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1055\/s-0037-1615407","article-title":"Homozygous G20210A prothrombin gene mutation without thromboembolic events: a case report","volume":"80","author":"Alatri","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lpm.2024.104247_bib0078","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0049-3848(01)00406-6","article-title":"Recurrent pulmonary embolism in a 13-year-old male homozygous for the prothrombin G20210A mutation combined with protein S deficiency and increased lipoprotein(a)","volume":"105","author":"Kosch","year":"2002","journal-title":"Thromb Res"},{"key":"10.1016\/j.lpm.2024.104247_bib0079","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0735-1097(00)01080-9","article-title":"G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism","volume":"37","author":"Miles","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2024.104247_bib0080","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/s-0037-1614409","article-title":"The risk of early recurrent venous thromboembolism after oral anticoagulant therapy in patients with the G20210A transition in the prothrombin gene","volume":"81","author":"Eichinger","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lpm.2024.104247_bib0081","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1046\/j.1365-2141.2001.02827.x","article-title":"The risk of recurrent venous thromboembolism among heterozygous carriers of the G20210A prothrombin gene mutation","volume":"113","author":"De Stefano","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.lpm.2024.104247_bib0082","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.5858\/2002-126-1319-CALMOT","article-title":"Clinical and laboratory management of the prothrombin G20210A mutation","volume":"126","author":"McGlennen","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.lpm.2024.104247_bib0083","article-title":"Screening for inherited thrombophilia: indications and therapeutic implications","volume":"87","author":"De Stefano","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.lpm.2024.104247_bib0084","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1146\/annurev.med.51.1.169","article-title":"Management of patients with hereditary hypercoagulable disorders","volume":"51","author":"Kearon","year":"2000","journal-title":"Annu Rev Med"},{"issue":"23 Suppl.1","key":"10.1016\/j.lpm.2024.104247_bib0085","first-page":"I9","article-title":"Spencer FA: risk factors for venous thromboembolism","volume":"107","author":"Anderson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2024.104247_bib0086","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/1358863X18755927","article-title":"Hypercoagulable states in arterial and venous thrombosis: when, how, and who to test?","volume":"23","author":"Carroll","year":"2018","journal-title":"Vasc. Med."},{"key":"10.1016\/j.lpm.2024.104247_bib0087","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7326\/0003-4819-135-5-200109040-00013","article-title":"The thrombophilias: well-defined risk factors with uncertain therapeutic implications","volume":"135","author":"Bauer","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2024.104247_bib0088","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.5858\/2002-126-1281-LEOHWV","article-title":"Laboratory evaluation of hypercoagulability with venous or arterial thrombosis","volume":"126","author":"Van Cott","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.lpm.2024.104247_bib0089","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2141.2009.08022.x","article-title":"Clinical guidelines for testing for heritable thrombophilia","volume":"149","author":"Baglin","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.lpm.2024.104247_bib0090","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1515\/CCLM.2003.059","article-title":"Guidelines for the laboratory investigation of inherited thrombophilias. Recommendations for the first level clinical laboratories","volume":"41","author":"Carraro","year":"2003","journal-title":"Clin Chem Lab Med"},{"issue":"2 Suppl","key":"10.1016\/j.lpm.2024.104247_bib0091","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.lpm.2024.104247_bib0092","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s11239-015-1316-1","article-title":"Guidance for the evaluation and treatment of hereditary and acquired thrombophilia","volume":"41","author":"Stevens","year":"2016","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.lpm.2024.104247_bib0093","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1182\/bloodadvances.2023010177","article-title":"American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing","volume":"7","author":"Middeldorp","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.lpm.2024.104247_bib0094","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/archinte.163.9.1105","article-title":"Role of family history in identifying women with thrombophilia and higher risk of venous thromboembolism during oral contraception","volume":"163","author":"Cosmi","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.lpm.2024.104247_bib0095","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1055\/s-0038-1665437","article-title":"Selective screening for the factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?","volume":"78","author":"Schambeck","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.lpm.2024.104247_bib0096","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1056\/NEJM199011293232202","article-title":"Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis","volume":"323","author":"Heijboer","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2024.104247_bib0097","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2141.1994.tb04920.x","article-title":"The family history and inherited thrombophilia","volume":"87","author":"Briet","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.lpm.2024.104247_bib0098","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/archinte.166.7.729","article-title":"Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review","volume":"166","author":"Ho","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.lpm.2024.104247_bib0099","unstructured":"NICE guidelines. Venous thromboembolic diseases: diagnosis, management and thrombophilia testing. 26 march 2020, updated 2 august 2023. www.nice.org.uk\/guidance\/ng158"},{"key":"10.1016\/j.lpm.2024.104247_bib0100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.thromres.2022.12.001","article-title":"Adherence to thrombophilia testing guidelines ans its influence on anticoagulation therapy: a single-center cross-sectional study","volume":"223","author":"Vrotniakaite-Bajerciene","year":"2023","journal-title":"Thrombos Res"},{"key":"10.1016\/j.lpm.2024.104247_bib0101","doi-asserted-by":"crossref","first-page":"295\u2011306","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.lpm.2024.104247_bib0102","doi-asserted-by":"crossref","first-page":"1258\u201170","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2024.104247_bib0103","doi-asserted-by":"crossref","first-page":"1687\u2011702","DOI":"10.1002\/art.42624","article-title":"The 2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"75","author":"Barbhaiya","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.lpm.2024.104247_bib0104","doi-asserted-by":"crossref","first-page":"1296\u2011304","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2024.104247_bib0105","first-page":"1085\u201195","article-title":"Pathophysiology of Antiphospholipid Syndrome","volume":"122","author":"Green","year":"2022","journal-title":"Thromb Haemost."},{"key":"10.1016\/j.lpm.2024.104247_bib0106","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-024-01140-1","article-title":"Thrombin generation assay in antiphospholipid antibodies positive subjects as a personalized thrombotic risk assessment: state of the art and perspectives","author":"Foret","year":"2024","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.lpm.2024.104247_bib0107","doi-asserted-by":"crossref","first-page":"2993\u20118","DOI":"10.1093\/rheumatology\/keab853","article-title":"A new pro-thrombotic mechanism of neutrophil extracellular traps in antiphospholipid syndrome: impact on activated protein C resistance","volume":"61","author":"Foret","year":"2022","journal-title":"Rheumatol"},{"key":"10.1016\/j.lpm.2024.104247_bib0108","doi-asserted-by":"crossref","first-page":"7101\u201138","DOI":"10.1182\/bloodadvances.2023010177","article-title":"American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing","volume":"7","author":"Middeldorp","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.lpm.2024.104247_bib0109","doi-asserted-by":"crossref","first-page":"443\u201158","DOI":"10.1111\/bjh.18239","article-title":"Thrombophilia testing: a British society for haematology guideline","volume":"198","author":"Arachchillage","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.lpm.2024.104247_bib0110","unstructured":"Venous thromboembolic diseases: diagnosis, management and thrombophilia testing [Internet]. London: National Institute for Health and Care Excellence (NICE); 2023 [cit\u00e9 27 f\u00e9vr 2024]. (National Institute for Health and Care Excellence: Clinical Guidelines). Disponible sur: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK556698\/"},{"key":"10.1016\/j.lpm.2024.104247_bib0111","doi-asserted-by":"crossref","first-page":"2126\u201137","DOI":"10.1111\/jth.14935","article-title":"Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis","volume":"18","author":"Zuily","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.lpm.2024.104247_bib0112","doi-asserted-by":"crossref","first-page":"1661\u201170","DOI":"10.1182\/bloodadvances.2021005808","article-title":"Apixaban compared with warfarin to prevent thrombosis in thrombotic antiphospholipid syndrome: a randomized trial","volume":"6","author":"Woller","year":"2022","journal-title":"Blood Adv"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498224000265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498224000265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:38:34Z","timestamp":1732667914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498224000265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":112,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0755498224000265"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2024.104247","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of thrombophilia on venous thromboembolism management","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2024.104247","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104247"}}